Provectus Biopharmaceuticals, Inc. PVCT
0.05 USD 0.00 (+1.92%)
At closeNov 6, 2026, 4:00 PM EST
0.0475 Day range 0.0475
0.038 52-week range 0.077
- YTD
- -5.36%
- 1 year
- -17.19%
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 989.04K | 0 | 0 | 0 | 0 | |
| 989.04K | 0 | 0 | 0 | 0 | |
| -3.43M | -4.67M | -4.96M | -6.30M | -8.05M | |
| -3.55M | -5.54M | -6.68M | -6.92M | -8.15M | |
| -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 1.43M | 3.11M | 97.23K | 590.71K | 50.99K | |
| 2.04M | 3.51M | 589.20K | 1.48M | 1.99M | |
| 8.27M | 7.70M | 30.80M | 25.55M | 19.41M | |
| 2.18M | 1.74M | 23.80M | 20.60M | 13.93M | |
| -6.23M | -4.19M | -30.21M | -24.07M | -17.42M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -3.04M | -1.01M | -4.09M | -6.19M | -5.20M | |
| 1.37M | 4.02M | 3.60M | 6.75M | 5.15M | |
| -1.68M | 3.01M | -493.48K | 539.72K | -54.52K |